Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells

• Satoshi Koyama,

  Affiliation Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Tomohiro Omura ,

  * E-mail: omurat@kuhp.kyoto-u.ac.jp

  Affiliation Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Atsushi Yonezawa,

  Affiliation Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Satoshi Imai,

  Affiliation Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Shunsaku Nakagawa,

  Affiliation Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Takayuki Nakagawa,

  Affiliation Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Ikuko Yano,

  Affiliation Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Kazuo Matsubara

  Affiliation Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan

  ⨯